Background-Early menarche has been associated with increased risk of coronary heart disease
Introduction
Menarche is a marker of puberty and the onset of ovarian and other endocrine functions relating to reproduction. 1 The timing of menarche has been reported to influence cardiovascular and metabolic health in adolescence and young adulthood, 2-4 but its long-term impact on vascular health in middle-age is unclear. Several studies have suggested that early menarche is associated with increased risk of coronary heart disease [5] [6] [7] [8] [9] [10] [11] or stroke, 7 but findings have been inconsistent. [11] [12] [13] Some studies have shown associations between early menarche and coronary heart disease only among non-smokers, 9-11 while others have not adequately accounted for adult adiposity 6, 7, 9, 12 which is known to be associated with early menarche. [14] [15] [16] [17] Some suggested a non-linear association between menarcheal age and coronary heart disease risk 6, 7 but these studies could not examine variation in risk of coronary heart disease, or of other vascular diseases, over a wide range of menarcheal ages, as numbers of events were generally small. 11 It is also unclear if the relation with coronary heart disease is modified by smoking and low socioeconomic status, factors which are associated with both vascular disease 18, 19 and late menarche. 6, 14 In a cohort of over a million middle-aged UK women, we investigated the relation of age at menarche with incident coronary heart disease and examined the relationship separately by subgroups as defined by their adult body mass index, smoking and socioeconomic status. We also investigated the associations of menarcheal age with other vascular diseases, in particular, cerebrovascular and hypertensive disease.
Methods
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Downloaded from
National Health Service (NHS) screening programmes of England and Scotland between 1996 and 2001. Details of the study design and recruitment have been previously described in detail (www.millionwomenstudy.org). 20 Around 70% of women invited to attend the national breast cancer screening programme participated in the study, and our cohort members represented 1 in 4 women in the UK in the target age range at the time of recruitment. All participants gave their written consent to take part in the study. The Oxford and Anglia Multi-Centre Research Ethics
Committee approved the conduct of the study.
At recruitment, participants completed a questionnaire, which included questions on reproductive and medical history, weight, height, socio-demographic details and lifestyle habits.
We obtained information on deaths and hospitalization through linkage with NHS databases for hospital admissions and mortality. 21, 22 Hospital admissions data for in-patients and day-patients are available from the Hospital Episode Statistics 23 for participants in England (from 1 April 1997), and the Scottish Morbidity Records 24 for participants in Scotland (from 1 January 1981).
Hospital diagnoses and causes of death are coded using the International Classification of Diseases, Tenth Revision (ICD-10).
25
Women reported their age at menarche in single years, and were classified for this study as having an age at menarche of 10, 11, 12, 13, 14, 15, 16 or 17 years. In a subset comprising 394 participants who were also included in a nationally representative birth cohort study (National Survey of Health and Development), 26 age at menarche reported in middle age was correlated with that reported at the time of puberty (r=0.6), and the mean ages at menarche reported in middle age (13.0 years) and at puberty (12.9 years) were not significantly different (p=0.09). The regression dilution ratio, which estimates the relative attenuation of relative risks due to measurement error, was 0.44.
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We obtained information on deaths and hospitalization through linkage with NH HS S S da da d ta aba ba base se ses s s fo for hospital admissions and mortality. 21, 22 Hospital admissions data for in-patients and day-patients ar re e av av avai ai aila la labl bl ble e fr f om om m t the h Hospital Episode Statistics cs cs 2 23 23 for participant nt ts s in n E E En ng ngland (from 1 April 1 19 99 97 97), and the e S S Sco co ott tis i ish h Mo Mo Morb rb rbid id dit ity y y R Re Rec cor r rds 24 24 4 f fo for p par r rticip ip ipan ant t ts i in n S Sc Scot otla land n n (fr from om om 1 1 J J Jan an nua ua ary y y 1 1 198 98 9 1 1 1).
Ho Ho osp sp spit it ital al a d dia ia iag gn gnos os ses s s a an nd nd c c cau ause e es s of of of d d de ea eath th h a a are re re c c cod od ded ed ed u us sing ng ng t t the he he Int nt nter er rna na ati ti tion on nal l l C Cla la lass ss sif ific ic cat at ati ion n n o of of We defined incident coronary heart disease as the first hospital admission with a diagnosis of coronary heart disease (ICD-10 I20 to I25), or death with coronary heart disease as the underlying cause. Similarly, incident cerebrovascular disease (ICD-10 I60 to I69) and incident hypertensive disease (ICD-10 I10 to I15) were defined as first hospital admission or death with these conditions. Virtually all UK residents are registered with general practitioners, and general practice records are a comprehensive source of information about an individual's health and medical care. 27 In a study to assess reliability of vascular outcomes recorded in hospital admissions data, there was generally excellent agreement between vascular diagnoses recorded in hospital records and those reported by general practitioners.
27
Nine years after recruitment, non-fasting blood samples were collected at local general practice clinics for 16,954 randomly selected cohort participants. We assayed plasma concentrations of total cholesterol, high-density lipoprotein cholesterol, apolipoprotein B and apolipoprotein A 1 for this subgroup of women (details of laboratory methods in Methods supplement).
Statistical analysis
Our analysis is based on the 1,217,840 women who reported their age at menarche and, at baseline, had no reported or prior hospitalization for heart disease, cerebrovascular disease/stroke or cancer (except non-melanoma skin cancer). We used Cox regression to calculate hazard ratio, Nine years after recruitment, non-fasting blood samples were collected a at t lo o oca c c l l l ge ge gene ne nera ra r l l practice clinics for 16,954 randomly selected cohort participants. We assayed plasma co onc nc ncen en ent tr trat at atio io ion n ns o of f f t to total cholesterol, high-density y l li lip po oprotein choles es stero ol, l, l a a apolipoprotein B and ap po ol lip i oprotein n A A A 1 for or t thi hi is s su su subg bg bgro roup up up o of f f w w wom me en n n (de e eta a ails s o o of f la la ab bo ora rat to tory ry m met etho hods ds ds i in n Me Me Meth th thod od o s s s u upp pp pple le leme me m nt nt nt). ). ). . We also examined the risk of incident coronary heart disease by age at menarche in subgroups of women defined by their body mass index, smoking habit and socioeconomic status.
Statistical an an nal al alys ys ysis is is
To examine heterogeneity in the association of coronary heart disease across categories an nd d d al a l other co cov v var r riat ate e es w w wer er ere e e <5 < <5%, %, %, < < <3% % and d d < < <1% % %, r resp p pe ec ecti tive ve vely ly). ).
We We e f f fu ur urth ther er i inv nv ves s sti tig gate te ted d d th th the e e as ass so oci ci ciat at ati i ions ns ns b b by y ad addi di d ti ti tion on onal l lly ly ly a a adj dj jus us u ti ti ing ng g f fo o or r r re re repr pr prod od oduc ct t tiv ve ve f fa a act to tors of body mass index, smoking and socioeconomic status, we used likelihood ratio tests to compare multivariate Cox regression models with and without the interaction term for age at menarche and the relevant risk factor (both treated as categorical variables). In an additional sensitivity analysis, we evaluated the effects of reporting errors in menarcheal age on vascular disease risks by plotting the relative risks against estimated mean menarcheal ages as they would have been reported at puberty, within each category of menarcheal age reported in middle age.
We also report on the plasma concentrations of cholesterol and lipid subfractions by age at menarche. To test the heterogeneity of mean lipid concentration across menarcheal age categories, we compared linear regression models with and without the categorical term for menarcheal age in the model using likelihood ratio tests.
When comparing two groups, as described in the text, we report relative risks with their conventional 95% confidence interval (95% CI). When relative risks for multiple groups are presented, as in the figures and tables, we report relative risks with their 95% group-specific CIs, to allow direct comparison of risks between any two categories of menarcheal age even if neither of them is the reference group. 29 We used Stata 13.0 (StataCorp, College Station, USA) 30 to conduct our analyses.
Results
The mean age of study participants at recruitment was 56 (SD=4. When comparing two groups, as described in the text, we report relative risks with their co onv nv nven en enti ti tion on onal al al 95% 5% % c confidence interval (95% CI). ). W W When relative r ris is sks f f for or or m multiple groups are pres s sen e ted, as in in t t the e e f f fig ig igur ur res es s a a and nd nd t tab ab ble le es, s, w w we re e epo o ort r r rel lative ve ve r ris is sk ks s w wi ith h h th th hei ei e r 95 95% % % gr grou ou up-p--sp sp pec c cif if ific c ic C C CIs, o o a a all ll low ow ow d dir ir rec ec e t t co co om mp mpar aris s son on o of f f ri ri isk sk sks s s b be betw tw twee ee een n n an n ny y y t tw two o c ca cate te tego go gori ies es es o o of f me me m n n nar rc rche he eal al al a age ge ge e e eve en n n i if if n ne e eit th ther of them is the he r r ref ef e er er eren en e ce ce c g gro ro oup up up. respectively. At baseline, women with earlier menarche were, on average, slightly younger, had a higher body mass index and were slightly shorter than women with later menarche (Table) . The proportions of women in the lowest third of socioeconomic status or who were current smokers were lower among women with menarcheal age 12, 13 and 14 years than among women with earlier or later menarche. Women with earlier menarche were more likely to have reported hypertension, diabetes and hypercholesterolemia than those with later menarche at recruitment.
Women with late menarche were also least likely to engage in weekly strenuous exercise.
During an average follow-up of 11.6 years per woman (14.1 million person-years), 73,378 women had incident coronary heart disease (68,744 hospitalisations and 4,634 deaths).
Moreover, 25,362 women had incident cerebrovascular disease and 249,426 women had incident hypertensive disease (Table) . Supplementary Table 1) shows the relative risks of incident coronary heart disease by single year of age at menarche ( 10, 11 to 16, and 17 years). Women with menarche at age 13 years had the lowest risk. Compared to this group of women, the risks of incident coronary heart disease were significantly increased at both earlier and later ages at menarche. The highest risks were seen with menarche at ages 10 and 17 years, with relative risks of 1.27 (95% CI Moreover, 25,362 women had incident cerebrovascular disease and 249,426 wom m men n n h h had ad ad i i inc nc ncid i iden e t hypertensive disease (Table) . Table 1 ) show ow ws th h he e e r re relative risks of incident co oro o ona n ry heart rt d d dis i e ea ease se e b b by y si si sing ng ngl le le y y yea ea ear r o of of age e at t t me e en na arc che he he ( ( 10 0, 1 11 t to o 16 16 16 , an and d d 17 17 y y yea ea ears rs s). W W Wom om omen wi wi ith th th m m men enar ar rch ch che e a at t a a age ge g 13 3 3 ye year ar rs s ha ha had d d t th the e lo lo owe we wes st r r ri i isk sk k. Co Co Comp mp mpar ar ared ed d t t to o th h his is is g g gr ro rou up up o o of f wo wo w me me men, n, th he he r ri is isk ks ks of incident co coro ro rona na ary ry ry h h hea ea eart d d dis is sea ea as s se e e we we w re e e s sig ig igni ni n fi fi fica ca c nt nt ntly ly ly i inc nc cre re reas as ased ed ed a a at t t b bot ot o h h h ea ea earl rl rlie ie ier r an an and d d la la ate te ter r ages at t t respectively for exact menarcheal ages of 10 and 17 years compared to menarche at age 13 years.
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We then investigated the association between age at menarche and incident coronary disease separately within subgroups of women defined by their body mass index, smoking, or socioeconomic status (Figure 2 , further details in Supplementary Table 2 ). The U-shape relation between age at menarche and risk of coronary disease was evident in lean, overweight and obese women, among current, past and never smokers, or among low, middle and high socioeconomic groups. Menarche at ages 10 years and 17 years associated with the highest risks in all the subgroups studied, with no significant heterogeneity across the subgroups (all P>0.05).
We also examined the relation for coronary heart disease mortality. Because the number of deaths were relatively modest (N=4634), we limited the analyses to menarcheal ages 11, 12, Table 3 ).
The risk of incident cerebrovascular disease in relation to menarcheal age is shown in Figure 3 (further details in Supplementary Table 4) . Both early and late menarche were associated with increased risk for incident cerebrovascular disease, but the risk estimates were of smaller magnitude than those found for coronary heart disease. Compared with menarche at age 13 years, menarche at age 10 and 17 years were associated with significant excess risks of 16% (95% CI 9 to 24%) and 13% (95% CI 3 to 24%), respectively. Further adjustment for mediating and other confounding factors only slightly attenuated the risks (Supplementary Table 4 ). Similarly, we found small but significant increased risk for incident hypertensive
We also examined the relation for coronary heart disease mortality. Beca au u use e e th h he e e nu nu numb mb mber e of deaths were relatively modest (N=4634), we limited the analyses to menarcheal ages 11, 12, disease for menarche at age 10 and 17 years compared to menarche at age 13 years (Supplementary Figure 1 and further details in Supplementary Table 4 ).
In the sensitivity analysis exploring the effects of reporting errors in menarcheal age, the relationship between age at menarche and the vascular outcomes remained U-shaped, but the curve was steeper than estimated by the main analysis (Supplementary Figure 2) .
Finally, we examined the lipid profile of a subgroup of women by age at menarche. We found no significant variation in the mean plasma concentrations of cholesterol and other lipid subfractions across categories of menarcheal age (Supplementary Table 5 ).
Discussion
Coronary heart disease incidence varied significantly by age at menarche in this large cohort of UK women in middle age. The pattern of the association was U-shaped over single ages at menarche, the risk being lowest for menarche at age 13 years, and increasing with younger and older ages at menarche. This pattern did not differ significantly between lean, overweight and obese women, between current, past smokers and never smokers, or between women in low, middle and high socioeconomic groups. We also found similar U-shaped associations for incident cerebrovascular and hypertensive disease, although the magnitude of the risks for early and late menarche was weaker than that observed for coronary heart disease. To our knowledge, our study is the first to demonstrate a significant excess coronary and other vascular disease risk associated with both early and late ages at menarche.
A number of prospective studies have previously investigated the relation of menarcheal age with coronary heart disease (Supplementary Table 6 ). Some, but not all, have reported that early age at menarche was associated with increased risk of coronary heart disease incidence 5, 6
Coronary heart disease incidence varied significantly by age at menarche in this large cohort of UK UK K w w wo om omen en en i i in n n mi mi mid dd ddle age. The pattern of the ass s so o oc ci iation was U-sh sh haped ed d o o over single ages at m men na narche, the e ri ri isk sk sk b bei ei eing ng g l l low ow owes e est t fo fo or r me men narch he he at a a ag ge e 13 3 3 y ye yea a ars s, s, a an nd nd i inc ncr r rea a asin in ng g wi with th h y y you oung ng ger er a a an nd nd ol lde de der r ag ag ages es a a at t t me mena na narc rch he e. Th This s p p pat at atte te tern rn rn d did id i n n not ot ot di di iff ff f er er r s s sig igni ni n fi fi fica ca cant nt tly ly ly b b bet et twe we w e en en l lea ea an, n, n o o ove ve erw rw wei i igh gh ht t an an nd d obese wome en, n, n, b b bet et twe we ween en en c cur ur rre re rent n n , , pa pa past st st smo mo m ke ke kers rs rs a and nd nd ne ne neve v v r r r sm sm smok ok oker er ers, s, s o o or r r be be betw tw twee ee een n wo wo wome me men n n in low, or mortality. [7] [8] [9] [10] [11] Consistent with these reports, we found that early age at menarche was associated with increased risk of incident coronary heart disease. While others have reported an increased coronary disease risk with early menarche among non-smokers only, 9-11 we found similar associations among smokers and non-smokers alike. Several studies, including ours, have also shown an association between early menarche and higher body mass index in adulthood, [14] [15] [16] [17] but our findings have been adjusted for adult body mass index, and we found that the association of early menarche with coronary heart disease was similar in lean, overweight and obese women.
Previous studies have investigated the association of menarcheal age with cerebrovascular disease (Supplementary Table 7) . Most of these studies reported no significant relationship between cerebrovascular disease risk and age at menarche, 6, [8] [9] [10] [11] 13 with only one study suggesting an increased risk of cerebrovascular disease associated with early menarche. 7 In our cohort, we found a significant increase in cerebrovascular disease risk not only with early ( 10 years) but also with late ( 17 years) menarche. Moreover, we also found a similar Ushaped relationship between menarcheal age and hospitalization for hypertensive disease.
However, the increasing risks of incident cerebrovascular and hypertensive disease associated with earlier and later menarche were weaker in magnitude than the risks of coronary heart disease.
Early age at menarche has been associated with increased blood pressure, 6, 15, 17 which is consistent with our finding of an increased risk of incident hypertensive disease in women with early menarche. Hypertension may, therefore, partly explain the association of early menarche with coronary heart disease and cerebrovascular disease. Further, in our cohort as well as in others, early menarche is associated with diabetes as well as with a history of hypercholesterolemia. 6, 16, 31 These findings suggest that impaired glucose homeostasis and elationship between cerebrovascular disease risk and age at menarche, 6, [8] [9] [10] [11] 13 w wi i ith h h on n nly ly ly o o one ne ne tudy suggesting an increased risk of cerebrovascular k disease associated with early menarche. 7 In ou ur r r co co coho ho hort rt rt, , w w we f fou ou oun nd a significant increase in ce e ere re r b br rovascular dis sea e e se e r r ris is isk k not only with early dyslipidemia, together with hypertension, are important mediating factors for the relation of early menarche with risks of coronary and cerebrovascular disease. Adjusting for these mediating factors attenuated the results but the risk estimates remained significant (Supplementary Tables   1 and 4) . Moreover, the adjustment for reported hypercholesterolemia had little effect on the risk estimates as shown for coronary heart disease (Supplementary Table 1) , consistent with our finding of little variation in the lipid profile of women across categories of menarcheal age (see Supplementary Table 5 ).
While some suggested that the association between age at menarche and coronary heart disease may be non-linear, 6 , 7 none of the previous studies have reported a significant increase in risk with late menarche. As observed in other cohorts, 14 the proportion of current smokers among our participants is notably increased at later ages at menarche but we adjusted for smoking, and the U-shaped relationship between menarcheal age and risk of coronary heart disease did not differ significantly across subgroups of women with different smoking patterns. Indeed, the risk estimates associated with late menarche ( 17 years) for every vascular disease outcome that we examined were hardly altered by adjusting for potential mediating factors. Even the risk for incident hypertensive disease associated with late menarche, though significant, was relatively small. In one study, late menarche was associated with increased brachial artery diameter and reduced flow-mediated dilation, suggestive of systemic subclinical atherosclerosis, 32 so endothelial dysfunction may play a role in the excess risk of coronary and cerebrovascular disease associated with late menarche.
Our study participants were mostly in their late 50s when recruited, but many of them are still currently in their 60s and 70s. While our findings are likely to apply to such women in contemporary populations, menarcheal age varies within and between populations 33, 34 and our isk with late menarche. As observed in other cohorts, 14 the proportion of current nt t smo mo m ke ke kers rs rs a a amo mo m ng our participants is notably increased at later ages at menarche but we adjusted for smoking, and h he e U-U-U-sh sh shap ap ped ed ed rel lat at atio io i nship between menarcheal a a ag g ge and risk of co oro ro r na ary ry y h h heart disease did not d di diff f fer e significa ant nt tly y y a acr cr ros s ss s su su subg bg bgro roup up ups s s o of w wom m me en w wit th h di di iff ff fer ere en ent t sm sm mo ok kin ing g g p pa att tte er ern ns ns. I I Ind nd ndee ee ed, , , t the e he r r ri isk es sti ti tima ma mate te t s s as as ass so soci cia a ate ed ed w w wit th h la l te te e m m men en enar a arch ch he e ( ( ( 1 1 17 y y yea ea ears rs) ) ) fo fo or ev ev eve e ery y y va va vasc c cul ul ular ar r d d dis isea ea ase se e o out ut utc co com m me t t tha hat t t w we we examined wer er re e e ha ha ard rd rdly ly ly a a alt l er er red ed ed b by y y ad ad adju ju j st st tin in ing g g fo fo for r r po po pote te ent nt ntia i l l l me me medi di d at at atin in ing g fa fa fact ct ctor or ors. s. s E E Eve ve en n n th th the e e ri ri r sk for by guest on April 17, 2017 http://circ.ahajournals.org/ Downloaded from findings may not be generalizable to populations with very different distributions of age at menarche. Further, mean age at menarche has been declining over time, 34, 35 but the fall in mean menarcheal age has been relatively small, and the differences in risk for each single year of menarcheal age in our study are also small. However, the shift towards younger age at menarche over time would mean an increase in the proportion with early menarcheal age in the future.
Although mechanisms underlying the variation in the timing of menarche are unclear, childhood obesity, which is highly prevalent in many populations, 36 has been consistently associated with early menarche. 37, 38 Public health strategies to reduce childhood obesity, if successful, could have an added benefit of achieving ages at menarche with favourable vascular health outcomes in the long-term.
The main strengths of this prospective study are its size and virtually complete follow-up for hospital and fatal vascular disease outcomes, allowing us to examine disease risk in detail across a wide range of menarcheal ages. Women were asked in middle-age to recall their age at menarche, but the likely effect of reporting errors would be to attenuate risk estimates so that the observed relationship implies, if anything, even steeper U-shaped relationships than suggested in Figure 2) . In addition, while we adjusted for age, adiposity, lifestyle factors, socioeconomic status, reproductive factors, and known clinical vascular risk factors, we cannot rule out residual confounding by factors that we have not measured.
In this large cohort of middle-aged UK women, both early and late ages at menarche are associated with significantly increased risk of incident coronary heart disease. There are similar, but weaker, U-shaped relationships for incident cerebrovascular and hypertensive disease.
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( ) , ( Table 2 ).
RRs (hazard ratios) stratified by region of recruitment, and adjusted for year of birth, body mass index, height, smoking, alcohol consumption, exercise, and socioeconomic status except when this is the factor under consideration; Reference category = menarche at age 13 years; Area of square is inversely proportional to the variance of the log risk. Table 2) .
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Relative risk (95% CI)
Coronary heart disease (ICD−10: I20 to I25) Beckman Synchron CX autoanalyzers (Beckman Coulter, High Wycombe, UK), we measured total cholesterol by enzymatic assay in EDTA plasma and apolipoprotein B (ApoB) and A1 (ApoA1) by immunoturbimetric assay but we measured high-density lipoprotein cholesterol (HDL-cholesterol) directly. The coefficients of variation were as follows: for total cholesterol=1.6% and 1.5% at a mean value of 3.5 mmol/L and 6.7 mmol/L, respectively; for HDL-cholesterol=2.6% and 2.1% at a mean value of 0.76 mmol/L and 1.82 mmol/L, respectively; for ApoB=2.9% and 3.6% at a mean value of 0.88 g/L and 1.12 g/L, respectively; and for ApoA 1 =3.1% and 2.9% at a mean value of 1.24 g/L and 1.50 g/L, respectively.
